ARTICLE | Clinical News
Adenovirus delivery: Received approval of a Phase I/II
September 26, 1994 7:00 AM UTC
GenVec, Rockville, Md. Product: Adenovirus delivery of the gene defective in cystic fibrosis Indication: Cystic fibrosis Status: Received RAC approval of a Phase I/II protocol to test safety and effic...